Bionomics looks to Nasdaq as its route to growth

August 4, 2021 NEWS

MELBOURNE: Peter Thiel-backed anxiety medication developer Bionomics says it’s considering a Nasdaq listing. The ASX

To read the full story...SUBSCRIBE NOW